Dyslipidemia in pediatric type 2 diabetes mellitus
B Sunil, AP Ashraf - Current diabetes reports, 2020 - Springer
Abstract Purpose of Review Cardiovascular (CV) disease is a major cause of mortality in
type 2 diabetes mellitus (T2D). Dyslipidemia is prevalent in children with T2D and is a …
type 2 diabetes mellitus (T2D). Dyslipidemia is prevalent in children with T2D and is a …
Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes
OBJECTIVE: Because cardiovascular disease (CVD) is the leading cause of death in
patients with type 1 diabetes (T1D) and dyslipidemia is an important CVD risk factor, we …
patients with type 1 diabetes (T1D) and dyslipidemia is an important CVD risk factor, we …
Hypertriglyceridemia in diabetes mellitus: implications for pediatric care
JC Hartz, S de Ferranti, S Gidding - Journal of the Endocrine …, 2018 - academic.oup.com
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in type 1
diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). It is estimated that the risk of …
diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). It is estimated that the risk of …
Dyslipidemia in youth with diabetes: to treat or not to treat?
There are an estimated 1.5 million people with type 1 diabetes (T1D) and 20 million with
type 2 diabetes (T2D) in the US today, including at least 150 000 under age 20 years. 1 Of …
type 2 diabetes (T2D) in the US today, including at least 150 000 under age 20 years. 1 Of …
A longitudinal assessment of lipids in youth with type 1 diabetes
Southern Reh CM, Mittelman SD, Wee C‐P, Shah AC, Kaufman FR, Wood JR. A longitudinal
assessment of lipids in youth with type 1 diabetes. Background: Type 1 diabetes and …
assessment of lipids in youth with type 1 diabetes. Background: Type 1 diabetes and …
Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus
EAC Sellers, G Yung, HJ Dean - Pediatric Diabetes, 2007 - Wiley Online Library
Objective: The objectives of this study were to describe the prevalence of dyslipidemia in a
population of youth with type 2 diabetes mellitus (T2DM) and to examine the relationship …
population of youth with type 2 diabetes mellitus (T2DM) and to examine the relationship …
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
WE Corpeleijn, WJ de Waal, HS Schipper, A Wiegman - Diabetologia, 2024 - Springer
In the last few decades, atherosclerotic cardiovascular disease (ASCVD) risk has decreased
dramatically among individuals affected by familial hypercholesterolaemia (FH) as a result of …
dramatically among individuals affected by familial hypercholesterolaemia (FH) as a result of …
Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study
AK Kershnar, SR Daniels, G Imperatore, SL Palla… - The Journal of …, 2006 - Elsevier
OBJECTIVE: Assessment of the prevalence of serum lipid abnormalities in US youth with
type 1 or type 2 diabetes. STUDY DESIGN: The SEARCH for Diabetes in Youth Study was a …
type 1 or type 2 diabetes. STUDY DESIGN: The SEARCH for Diabetes in Youth Study was a …
Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes
S Krishnan, KR Short - Journal of the cardiometabolic …, 2009 - Wiley Online Library
Type 1 diabetes (T1D) is a common disease of childhood with a current prevalence of
almost 2 cases per 1000 adolescents, according to the third National Health and Nutrition …
almost 2 cases per 1000 adolescents, according to the third National Health and Nutrition …
Update on screening, etiology, and treatment of dyslipidemia in children
V Bamba - The Journal of Clinical Endocrinology & Metabolism, 2014 - academic.oup.com
Context: Cardiovascular disease is a leading cause of morbidity and mortality. Early
identification and treatment of risk factors that accelerate this condition are paramount to …
identification and treatment of risk factors that accelerate this condition are paramount to …